Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.
The report details the trend, potential and market size of Peptide Based Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide Based Cancer Therapeuticsmarket, defines the market attractiveness level of Peptide Based Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide Based Cancer Therapeutics industry, describes the types of Peptide Based Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide Based Cancer Therapeutics market and the development prospects and opportunities of Peptide Based Cancer Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide Based Cancer Therapeutics market in Chapter 13.
By Player:
Johnson & Johnson
Valeant Pharmaceuticals Inc
Amgen, Inc
AstraZeneca PLC
AbbVie Inc
Takeda Pharmaceutical
Teva Pharmaceuticals
Pfizer Inc
Abbott
Allergan plc
By Type:
Goserelin
Bortezomib
leuprorelin
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide Based Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide Based Cancer Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide Based Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide Based Cancer Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide Based Cancer Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Peptide Based Cancer Therapeutics Consumption (2017-2022)
-
7.2 United States Peptide Based Cancer Therapeutics Consumption (2017-2022)
-
7.3 Europe Peptide Based Cancer Therapeutics Consumption (2017-2022)
-
7.4 China Peptide Based Cancer Therapeutics Consumption (2017-2022)
-
7.5 Japan Peptide Based Cancer Therapeutics Consumption (2017-2022)
-
7.6 India Peptide Based Cancer Therapeutics Consumption (2017-2022)
-
7.7 South Korea Peptide Based Cancer Therapeutics Consumption (2017-2022)
8 Region and Country-wise Peptide Based Cancer Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide Based Cancer Therapeutics Consumption Forecast (2022-2028)
9 Global Peptide Based Cancer Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide Based Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Goserelin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bortezomib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global leuprorelin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide Based Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Peptide Based Cancer Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Goserelin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bortezomib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global leuprorelin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide Based Cancer Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide Based Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide Based Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide Based Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide Based Cancer Therapeutics Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Peptide Based Cancer Therapeutics Product and Service
-
14.2 Valeant Pharmaceuticals Inc
-
14.2.1 Valeant Pharmaceuticals Inc Company Details
-
14.2.2 Valeant Pharmaceuticals Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Valeant Pharmaceuticals Inc Peptide Based Cancer Therapeutics Product and Service
-
14.3 Amgen, Inc
-
14.3.1 Amgen, Inc Company Details
-
14.3.2 Amgen, Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen, Inc Peptide Based Cancer Therapeutics Product and Service
-
14.4 AstraZeneca PLC
-
14.4.1 AstraZeneca PLC Company Details
-
14.4.2 AstraZeneca PLC Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca PLC Peptide Based Cancer Therapeutics Product and Service
-
14.5 AbbVie Inc
-
14.5.1 AbbVie Inc Company Details
-
14.5.2 AbbVie Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AbbVie Inc Peptide Based Cancer Therapeutics Product and Service
-
14.6 Takeda Pharmaceutical
-
14.6.1 Takeda Pharmaceutical Company Details
-
14.6.2 Takeda Pharmaceutical Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceutical Peptide Based Cancer Therapeutics Product and Service
-
14.7 Teva Pharmaceuticals
-
14.7.1 Teva Pharmaceuticals Company Details
-
14.7.2 Teva Pharmaceuticals Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Pharmaceuticals Peptide Based Cancer Therapeutics Product and Service
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Details
-
14.8.2 Pfizer Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Inc Peptide Based Cancer Therapeutics Product and Service
-
14.9 Abbott
-
14.9.1 Abbott Company Details
-
14.9.2 Abbott Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbott Peptide Based Cancer Therapeutics Product and Service
-
14.10 Allergan plc
-
14.10.1 Allergan plc Company Details
-
14.10.2 Allergan plc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Allergan plc Peptide Based Cancer Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide Based Cancer Therapeutics
-
Figure Peptide Based Cancer Therapeutics Picture
-
Table Global Peptide Based Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Based Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Based Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide Based Cancer Therapeutics Consumption by Country (2017-2022)
-
Figure United States Peptide Based Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide Based Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Peptide Based Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide Based Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Peptide Based Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide Based Cancer Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Based Cancer Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide Based Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Goserelin Consumption and Growth Rate (2017-2022)
-
Figure Global Bortezomib Consumption and Growth Rate (2017-2022)
-
Figure Global leuprorelin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Goserelin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bortezomib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global leuprorelin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide Based Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide Based Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Peptide Based Cancer Therapeutics Product and Service
-
Table Valeant Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Inc Peptide Based Cancer Therapeutics Product and Service
-
Table Amgen, Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen, Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen, Inc Peptide Based Cancer Therapeutics Product and Service
-
Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PLC Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Peptide Based Cancer Therapeutics Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Peptide Based Cancer Therapeutics Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Peptide Based Cancer Therapeutics Product and Service
-
Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Peptide Based Cancer Therapeutics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Peptide Based Cancer Therapeutics Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Peptide Based Cancer Therapeutics Product and Service
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Peptide Based Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Peptide Based Cancer Therapeutics Product and Service
-
